India, April 27 -- Cohance Lifesciences Limited has announced the appointment of Umang Vohra as Executive Chairman (effective May 1, 2026) and Group CEO (effective May 20, 2026), marking a key leadership transition as the company enters its next growth phase.
Vohra will succeed Vivek Sharma, who is stepping down from the role for personal reasons and will continue as an advisor for the next nine months to ensure a smooth transition.
The appointment reflects a strategic move by the board to bring in leadership aligned with the company's transformation and expansion plans. Cohance has established a strong presence in the global CDMO space, with capabilities across complex chemistry, APIs, ADCs, oligonucleotides, and performance materials.
...